About-cancer/treatment/drugs/filgrastim/zh
菲格拉斯汀
該頁面包含有關非格司亭的簡要信息，以及一些鏈接，這些鏈接指向有關該藥物的使用，研究結果和正在進行的臨床試驗的更多信息。
美國品牌名稱
格蘭尼克斯
神經元
扎爾西奧
FDA批准
是
該藥物的FDA標籤信息可從DailyMed獲得。
用於癌症
Filgrastim被批准用於減少以下患者的感染機會：
- 中性粒細胞減少症 由某些類型的化療引起，包括：
- 急性髓細胞白血病的化學療法。
- 非骨髓癌患者骨髓移植前的清髓性化學療法。
- 非骨髓癌患者的骨髓抑制化療。
Filgrastim還被批准用於幫助將幹細胞從骨髓轉移到血流中，以便可以收集，儲存它們，然後通過自體幹細胞移植將其送回患者手中。
非格拉斯汀也被批准用於治療不是由癌症引起的中性粒細胞減少症。
Filgrastim is also available in a different form called pegfilgrastim. For more information, see the Drug Information Summary for Pegfilgrastim.
More About Filgrastim
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Filgrastim - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Immune System Modulators
Clinical Trials Accepting Patients
Find Clinical Trials for Filgrastim - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
